Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Nosocomial Bacteremia and Mortality in Zambian Neonates
NCT02386592Completed
- Sponsor
- Boston University
- Start
- Sep 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chlorhexidine in neonatal sepsis (2 arms), sponsored by Boston University. Primary endpoint: All-cause neonatal mortality at 18 months. Started Sep 2015; status: completed.
02
Drugs
chlorhexidine
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on NCT02386592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02386592.